AccueilCHJTF • OTCMKTS
add
CSPC Pharmaceutical Group Ltd
Dernière clôture
0,67 $
Plage sur l'année
0,54 $ - 0,96 $
Capitalisation boursière
59,63 Md HKD
Volume moyen
1,33 k
Ratio cours/bénéfices
-
Rendement (dividendes)
-
Place boursière principale
HKG
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Chiffre d'affaires | 6,40 Md | -17,76 % |
Charges d'exploitation | 3,43 Md | -10,23 % |
Résultat net | 757,66 M | -50,40 % |
Marge bénéficiaire nette | 11,84 | -39,65 % |
Bénéfice par action | — | — |
EBITDA | 1,13 Md | -41,98 % |
Taux d'imposition effectif | 20,44 % | — |
Bilan
Total des actifs
Total du passif
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Trésorerie/Invest. court terme | 10,82 Md | — |
Total des actifs | — | — |
Total du passif | — | — |
Total des capitaux propres | 36,47 Md | — |
Actions en circulation | 11,71 Md | — |
Ratio cours/valeur comptable | 0,23 | — |
Rentabilité des actifs | — | — |
Retour sur capitaux | 6,09 % | — |
Flux de trésorerie
Variation nette en trésorerie
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Résultat net | 757,66 M | -50,40 % |
Trésorerie (opérations) | — | — |
Trésorerie (invest.) | — | — |
Trésorerie (financement) | — | — |
Variation nette en trésorerie | — | — |
Flux de trésorerie dispo. | — | — |
À propos
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
Date de fondation
1992
Site Web
Employés
20 300
